Videos

Key points to remember when performing cardiac ablations in ASCs
When CMS finalized coverage for cardiac ablations performed in ASCs, experts from HRS and ACC published recommendations for performing those procedures safely and effectively. One of the cardiologists behind that guidance shared some important takeaways with Cardiovascular Business.
ASNC speaks to policymakers about prior authorization, Medicare cuts and more
The American Society of Nuclear Cardiology visited Capitol Hill to advocate for a variety of issues. Cardiovascular Business spoke to the group's president to learn more.
AATS helps heart surgeons diagnose and manage heparin-induced thrombocytopenia
Heparin-induced thrombocytopenia after heart surgery is a major concern, but prior guidelines were developed without much feedback from actual cardiac surgeons.
Upfront costs of robotic heart surgery are high—but it may be a smart investment
Makoto Hashimoto, MD, PhD, said robotic procedures are associated with a faster recovery time and many other potential benefits.
Resilia tissue developed by Edwards Lifesciences associated with long-term durability
Kevin Accola, MD, spoke to Cardiovascular Business about new 10-year data on the performance of surgical valves featuring Resilia tissue. The findings are good news for Edwards Lifesciences, which also includes the tissue on many of its TAVR devices.

$iad Ali, MD, DPhil, director of the DeMatteis Cardiovascular Institute and director investigational interventional cardiology, St. Francis Hospital and Heart Center, explains how coronary computed tomography angiography (CCTA) offers a shift in cardiac care and interventional cardiology because of the information it offers on plaque burden and ischemia based on fractional flow reserve CT (FFR-CT). #TCT #YesCCT$

CCTA becoming an essential tool for interventional cardiologists

Ziad Ali, MD, explains how coronary computed tomography angiography is creating a major shift in cardiac care.

Nathaniel Lebowitz, MD, in charge of preventive cardiology at Hackensack University Medical Center, and assistant professor of internal medicine at Hackensack Meridian School of Medicine, gives an overview of where things are at with lipoprotein (a) awareness, testing and drug development. He and is working on the American Heart Associations (AHA) Lp(a) Discovery Project to expand awareness to both physicians and patients. #AHA #LPA

Cardiologist discusses Lp(a), the CVD risk factor responsible for many surprise heart attacks

Cardiologist Nathaniel Lebowitz, MD, reviews the latest updates in lipoprotein(a) awareness, testing and drug development.

Rich Fabian, Medical Imaging Technology at AdvaMed Imaging chair of board, a medtech industry group made up of medical imaging companies to address higher level trends and public policy concerns, said tariffs are having a major impact for all vendors due to diverse supply chains that cannot be changed overnight. He said the U.S. tariffs and counter tariffs from, various countries will raise costs for U.S. health systems at a time where margins for them are already razor thin. #RSNA

Medical imaging industry group shares tariff concerns

AdvaMed, a medtech industry group made up of medical imaging companies, says tariffs are having a major impact for all vendors.

Andres Cordova, MD, cardiology fellow, University of Vermont Medical Center, explains a study of registry and outcomes data on the use of Impella hemodynamic support in elderly STEMI patients with cardiogenic shock.

Impella use fails to improve mortality in elderly patients

The Impella CP heart pump is being used more and more to treat cardiogenic shock, and the benefits are clear. For many older patients, however, the technology seem to fall short.

Transcatheter treatment of tricuspid valve disease has rapidly evolved over the past two years, giving physicians new tools to address a condition long considered under treated due to limited procedural options and complex anatomy. Ryan K. Kaple, MD, FACC, FSCAI, director of the structural and congenital heart program at Hackensack University Medical Center, spoke top Cardiovascular Business about recent advances and his center's real-world experience.

Key trends in transcatheter tricuspid valve repair and replacement

The interventional treatment of tricuspid valve disease has evolved in recent years thanks to new research and critical FDA approvals. Cardiologist Ryan Kaple, MD, reviewed this trend for a new video interview.

Walter Wiggins, MD, PhD, a neuroradiologist and director of clinical AI at Mosaic, explains how large language model (LLM) artificial intelligence is increasingly being used in radiology to extract structured data from narrative radiology reports to improve workflow, and to help validate, monitor and improve other AI tools being used in clinical practice.

How Radiology Partners is using large language models to monitor AI deployment

This type of tracking helps a practice understand how radiologists interact with AI, whether they're appropriately rejecting incorrect results, and if the technology is improving detection of important findings.

Samir B. Pancholy, MD, chief interventional cardiologist, Wayne Memorial Hospital in Honesdale, Pennsylvania, discusses the differences in the business models for office based labs (OBL) vs ambulatory surgical centers (ASC) and choosing the right model cardiovascular and vascular procedures. #TCT #SCAI #OBL #ASC

Cardiologist highlights key differences between OBLs and ASCs

Current payment policies have health systems and physicians all over the country looking to learn more about these two business models.

Video interview: GE Healthcare showcased its new FDA 510(k)-pending Photonova Spectra photon-counting computed tomography (CT) scanner for the first time at the 2025 Radiological Society of North America (RSNA) meeting, which will likely become the second vendor to offer a workhorse photon-counting system. Tim Szczykutowicz, PhD, associate professor of radiology and director of clinical operations for CT protocol at the University of Wisconsin–Madison, has worked on the system for several years. #RSNA

Overview of the new GE HealthCare photon-counting scanner technology

Tim Szczykutowicz, PhD, associate professor radiology, University of Wisconsin Madison, explains the new technology developments in GE HealthCare's FDA 510(k)-pending photon-counting CT scanner.

Videos

Key points to remember when performing cardiac ablations in ASCs

ASNC speaks to policymakers about prior authorization, Medicare cuts and more

AATS helps heart surgeons diagnose and manage heparin-induced thrombocytopenia

Upfront costs of robotic heart surgery are high—but it may be a smart investment

Resilia tissue developed by Edwards Lifesciences associated with long-term durability